Los Angeles Capital Management LLC Iovance Biotherapeutics, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 61,759 shares of IOVA stock, worth $364,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,759
Previous 24,124
156.01%
Holding current value
$364,995
Previous $193,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IOVA
# of Institutions
316Shares Held
239MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$161 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$157 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$142 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$125 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$78 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $933M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...